Evidence map›Paper›PMID 20692725›Full record

ArticleJournal of the American Academy of Dermatology2010

A pilot study of emollient therapy for the primary prevention of atopic dermatitis.

Eric L Simpson, Trista M Berry, Peter A Brown, Jon M Hanifin

Abstract read
In one paragraph

Article in Journal of the American Academy of Dermatology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Emollients and moisturisers for eczema.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Pooled it
  3. Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT.Health technology assessment (Winchester, England) · 2024
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Atopic dermatitis.Nature reviews. Disease primers · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.The journal of allergy and clinical immunology. In practice · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Significance of Skin Barrier Dysfunction in Atopic Dermatitis.Allergy, asthma & immunology research · 2018
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eric L SimpsonDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon 97239-4501, USA. simpsone@ohsu.edu
Trista M Berry
Peter A Brown
Jon M Hanifin
Oregon Health & Science University · US

Funding

The Role of the Skin Barrier in Atopic Dermatitis Development and PreventionK23AR057486 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI SIMPSON, ERIC L · 2010 to 2013
$513k
NIAMS NIH HHS K23 AR057486
6 · The paper itself

Abstract

backgroundPrevention strategies in atopic dermatitis (AD) using allergen avoidance have not been consistently effective. New research reveals the importance of the skin barrier in the development of AD and possibly food allergy and asthma. Correcting skin barrier defects from birth may prevent AD onset or moderate disease severity.

objectiveWe sought to determine the feasibility of skin barrier protection as a novel AD prevention strategy.

methodsWe enrolled 22 neonates at high risk for developing AD in a feasibility pilot study using emollient therapy from birth.

resultsNo intervention-related adverse events occurred in our cohort followed up for a mean time of 547 days. Of the 20 subjects who remained in the study, 3 (15.0%) developed AD, suggesting a protective effect when compared with historical controls. Skin barrier measurements remained within ranges seen in normal-appearing skin. LIMITATIONS: No conclusions regarding efficacy can be made without a control group.

conclusionsSkin barrier repair from birth represents a novel and feasible approach to AD prevention. Further studies are warranted to determine the efficacy of this approach.

Indexed as

AsthmaDermatitis, AtopicDrug CombinationsEmollientsFeasibility StudiesFemaleFollow-Up StudiesFood HypersensitivityHumansInfant, NewbornMalePilot ProjectsPrimary PreventionPropylene GlycolsProspective StudiesRisk Assessmentcetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotionDrug CombinationsEmollientsPropylene GlycolsSodium Dodecyl Sulfate

Identifiers

PMID20692725
PMCPMC3156679
OpenAlexW2147401052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.